Independent evaluation of tolerance of therapeutic plasma inactivated by amotosalen‐HCl–UVA (Intercept™) over a 5‐year period of extensive delivery

Publisher： John Wiley & Sons Inc

E-ISSN： 1423-0410|109|4|414-416

ISSN： 0042-9007

Source： VOX SANGUINIS, Vol.109, Iss.4, 2015-11, pp. : 414-416

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Comparative effectiveness of plasma prepared with amotosalen‐UVA pathogen inactivation and conventional plasma for support of liver transplantation

By  

TRANSFUSION, Vol. 55, Iss. 7, 2015-07 ,pp. : 1710-1720

John Wiley & Sons Inc

Access to resources Recommend Favorite

The Science of Safety: Toxicological Review of Amotosalen HCl

By  

Transfusion Medicine and Hemotherapy, Vol. 31, Iss. 1, 2004-02 ,pp. : 17-23

Karger

Access to resources Recommend Favorite

Counting the cost of over‐the‐counter codeine containing analgesic misuse: A retrospective review of hospital admissions over a 5 year period

By  

DRUG AND ALCOHOL REVIEW, Vol. 37, Iss. 2, 2018-02 ,pp. : 247-256

John Wiley & Sons Inc

Access to resources Recommend Favorite

Presentation and outcome of clinical poor performance in one health district over a 5-year period: 2002–2007

By Cox Stephen J   Holden John D  

British Journal of General Practice, Vol. 59, Iss. 562, 2009-05 ,pp. : 344-348

Royal College of General Practitioners

Access to resources Recommend Favorite

Acute hepatitis B in blood donors over a 5‐year period in England and North Wales: who is getting infected?

By  

TRANSFUSION, Vol. 54, Iss. 6, 2014-06 ,pp. : 1660-1665

John Wiley & Sons Inc

Access to resources Recommend Favorite